Coronary stents, dual antiplatelet therapy and peri-operative problems;Koronare stents, duale antiplättchentherapie und die perioperative problematik

Anaesthesist

Volumn 56, Issue 4, 2007, Pages 401-412

  Metzler, H ^a   Huber, K ^b   Kozek Langenecker, S ^b   Vicenzi, M N ^a   Munch A ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Coronary stent implantation; Dual antiplatelet drug therapy; Percutaneous coronary intervention; Perioperative stent thrombosis; Regional anaesthesia

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOOXYGENASE 1; PACLITAXEL; RAPAMYCIN; THROMBOXANE A2; TICLOPIDINE;

BLEEDING; CARDIOVASCULAR RISK; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; GASTROINTESTINAL TOXICITY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NEUTROPENIA; PERCUTANEOUS CORONARY INTERVENTION; PEROPERATIVE COMPLICATION; REGIONAL ANESTHESIA; REVIEW; RISK FACTOR; SPINAL HEMATOMA; THROMBOCYTE FUNCTION; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT DURATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 34247279152     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1171-3     Document Type: Review

References (46)

1. ACC/AHA (2002) Guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. J Am Coll Cardiol 39: 542-553
2. ACC/AHA/SCAI (2006) Guideline update for percutaneous coronary intervention - summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 47: 216-235
3. Agarwal S, Coakely M, Reddy K (2006) Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100® ) and modified thrombelastography (mTEG® ) with light transmission platelet aggregometry. Anesthesiology 105: 676-683
4. Al Suwaidi J, Berger PB, Holmes DR (2000) Coronary artery stents. JAMA 284: 1828-1836
5. Ascione R, Gosh A, Rogers CA et al. (2005) In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg 79: 1210-1216
6. Auerbach A, Goldman L (2006) Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 113: 1361-1376
7. Beck KH, Mohr P, Bleckmann U (1995) Desmopressin effect on acetylsalicylic acid impaired platelet function. Semin Thromb Hemost [Suppl 2] 21: 32-39
8. Brilakis ES (2005) Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 96: 512-514
9. Curfman GD, Morrissey S, Jarcho JA et al. (2007) Drug-eluting-stents - promise and uncertaincy. N Engl J Med 356:1059-1060
10. Cutlip DE, Baim DS, Ho KK (2001) Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103: 1967-1971
11. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R (2005) Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedancebased whole blood platelet aggregation methods. Clin Appl Thromb Hemost 11: 25-35
12. Farb A, Boam AB (2007) Stent thrombosis redux - the FDA perspective. N Engl J Med 356: 984-987
13. Food and Drug Administration (2007) Circulation system devices advisory panel transcript for December 8 (2006), meeting. (Accessed January 25, 2007), http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4253t2.rtf
14. Gogarten W, VanAken H, Büttner J (2003) Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/ antithrombotische Medikation. Anästh Intensivmed 44: 218-230
15. Haase TT (2002) A contemporary overview of percutaneous coronary interventions. J Am Coll Cardiol 39: 1096-1113
16. Harding S, Severn A, Calvert J (2002) Aspirin and central neural blockade. Anesthesia 57: 304-305
17. Herbert JM, Bernat A, Maffrand JP (1993) Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat. Thromb Res 71: 433-441
18. Herbstreit F, Peters J (2005) Case report: spinal anaesthesia despite combined clopidogrel and aspirin therapy in a patient awaiting lung transplantation: effects of platelet transfusion on clotting tests. Anaesthesia 60: 85-87
19. Hezard N, Metz D, Nazeyrollas P (2002) PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty? Thromb Res 108: 43-47
20. Horlocker TT, Wedel DJ, Benzon H (2003) Regional anesthesia in anticoagulated patients: defining the risks (the second ASRA Conference of Neuroaxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 28: 172-198
21. Kaluza GL, Joseph J, Lee JR et al. (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35: 1288-1295
22. Kastrati A, Dibra A, Eberle S et al. (2005) Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: metaanalysis of randomized trials. JAMA 294: 819-825
23. Katritsis DG, Karvouni E, Ioannidis JP (2005) Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 95: 640-643
24. Koscielny J, Tempelhoff GF von, Ziemer S (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155-166
25. Kozek-Langenecker S, Fries D, Gütl M et al. (2005) Lokoregionalanästhesien unter gerinnungshemmender Medikation. Empfehlungen der Arbeitsgruppe Perioperative Gerinnung der Österreichischen Gesellschaft für Anästhesiologie und Intensivmedizin. Anaesthesist 54: 476-484
26. Lecompte T, Hardy J (2006) Antiplatelet agents and perioperative bleeding. Can J Anaesth 53: S103-S12
27. Luddington RJ (2005) Thrombelastography/ thrombelastometry. Clin Lab Haematol 27: 81-90
28. Mahla E, Lang T, Vicenzi M (2001) Thrombelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 92: 572-577
29. Matzdorff A (2005) Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemost 31: 393-399
30. McFadden EP, Stabile E, Regar E et al. (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364: 1519-1521
31. Merritt JC, Bhatt DL (2004) The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 17: 21-27
32. Muni NI, Gross TP (2004) Problems with drug-eluting stents - The FDA perspective. N Engl J Med 351: 1593-1594
33. Nordmann AJ, Briel M, Bucher HC (2006) Mortality in randomized controlled trials comparing drug-eluting stents vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27: 2784-2814
34. Posner KL (1999) Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 89: 553-560
35. Rodgers A, Walker N, Schug S (2000) Reduction of postoperative mortality with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 321: 1493
36. Samama CM, Baillard C (2001) Locoregional neuraxial anesthesia as used in vascular surgery. Can J Anaesth 48: 72-77
37. Scharbert G, Deutsch E, Kress H (2004) Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesia. Anesth Analg 99: 823-827
38. Tanaka KA, Szlam F, Kelly AB (2004) Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets 15: 325-332
39. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (2005) Guidelines for percutenous coronary interventions. Eur Heart J 26: 804-847
40. Tyagi A, Bhattacharya A (2002) Central neuraxial books and anticoagulation: a review of current trends. Eur J Anaesthesiol 19: 317-329
41. Van der Linden J, Lindvall G, Sartipy U (2005) Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation 112: 1276-1280
42. Vicenzi MN, Ribitsch D, Luha O et al. (2001) Coronary artery stenting before noncardiac surgery: more threat than safety? Anesthesiology 94: 367-368
43. Vicenzi MN, Meislitzer T, Heitzinger B et al. (2006) Coronary artery stenting and non-cardiac surgery- a prospective outcome study. Br J Anaesth 96: 686-693
44. Wenaweser P, Dorffler-Melly J, Imboden K et al. (2005) Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Card Cardiol 45: 1748-1752
45. Wilson SH, Fasseas P, Orford JL (2003) Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary artery stenting. J Am Coll Cardiol 42: 234-240
46. Yusuf SD, Zhao F, Mehta SR et al. (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345: 494-502